Xiang Liu , Meng Zhang , Yi Luo , Shijie Yan , Haoran Xu , Yao Yao , Farong Xu , Pinghuang Liu
{"title":"Surface expression of PEDV nucleocapsid protein facilitates NK cell-mediated ADCC via anti-N nonneutralizing antibody","authors":"Xiang Liu , Meng Zhang , Yi Luo , Shijie Yan , Haoran Xu , Yao Yao , Farong Xu , Pinghuang Liu","doi":"10.1016/j.vetmic.2025.110518","DOIUrl":null,"url":null,"abstract":"<div><div>The nucleocapsid (N) protein is the most abundant viral protein during porcine epidemic diarrhea virus (PEDV) infection and exhibits strong immunogenicity, prompting the host immune system to produce large quantities of antibodies against it. However, N-specific antibodies are non-neutralizing, as the N protein is typically located inside viral particles. Understanding the roles of N-specific antibodies during PEDV infection is crucial for developing more effective vaccines. In this study, we demonstrated that a significant amount of PEDV-N protein is expressed on the surface of living cells during PEDV infection or transient N expression. Mechanistically, the PEDV-N protein may reach the cell surface via the exosome secretion pathway. Furthermore, anti-N antibodies can bind to the surface N protein and induce antibody-dependent natural killer (NK) cell-mediated cytotoxicity (ADCC), directly killing PEDV-infected cells. Although anti-N antibodies lack neutralizing effects against PEDV infection, they can target the N protein present on the surface of PEDV-infected cells to induce NK cell-mediated ADCC, thus protecting the host from viral infection. Our results indicate that the N protein holds significant potential as a candidate for designing vaccines against porcine enteric viruses.</div></div>","PeriodicalId":23551,"journal":{"name":"Veterinary microbiology","volume":"305 ","pages":"Article 110518"},"PeriodicalIF":2.4000,"publicationDate":"2025-04-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Veterinary microbiology","FirstCategoryId":"97","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0378113525001531","RegionNum":2,"RegionCategory":"农林科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"MICROBIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
The nucleocapsid (N) protein is the most abundant viral protein during porcine epidemic diarrhea virus (PEDV) infection and exhibits strong immunogenicity, prompting the host immune system to produce large quantities of antibodies against it. However, N-specific antibodies are non-neutralizing, as the N protein is typically located inside viral particles. Understanding the roles of N-specific antibodies during PEDV infection is crucial for developing more effective vaccines. In this study, we demonstrated that a significant amount of PEDV-N protein is expressed on the surface of living cells during PEDV infection or transient N expression. Mechanistically, the PEDV-N protein may reach the cell surface via the exosome secretion pathway. Furthermore, anti-N antibodies can bind to the surface N protein and induce antibody-dependent natural killer (NK) cell-mediated cytotoxicity (ADCC), directly killing PEDV-infected cells. Although anti-N antibodies lack neutralizing effects against PEDV infection, they can target the N protein present on the surface of PEDV-infected cells to induce NK cell-mediated ADCC, thus protecting the host from viral infection. Our results indicate that the N protein holds significant potential as a candidate for designing vaccines against porcine enteric viruses.
期刊介绍:
Veterinary Microbiology is concerned with microbial (bacterial, fungal, viral) diseases of domesticated vertebrate animals (livestock, companion animals, fur-bearing animals, game, poultry, fish) that supply food, other useful products or companionship. In addition, Microbial diseases of wild animals living in captivity, or as members of the feral fauna will also be considered if the infections are of interest because of their interrelation with humans (zoonoses) and/or domestic animals. Studies of antimicrobial resistance are also included, provided that the results represent a substantial advance in knowledge. Authors are strongly encouraged to read - prior to submission - the Editorials (''Scope or cope'' and ''Scope or cope II'') published previously in the journal. The Editors reserve the right to suggest submission to another journal for those papers which they feel would be more appropriate for consideration by that journal.
Original research papers of high quality and novelty on aspects of control, host response, molecular biology, pathogenesis, prevention, and treatment of microbial diseases of animals are published. Papers dealing primarily with immunology, epidemiology, molecular biology and antiviral or microbial agents will only be considered if they demonstrate a clear impact on a disease. Papers focusing solely on diagnostic techniques (such as another PCR protocol or ELISA) will not be published - focus should be on a microorganism and not on a particular technique. Papers only reporting microbial sequences, transcriptomics data, or proteomics data will not be considered unless the results represent a substantial advance in knowledge.
Drug trial papers will be considered if they have general application or significance. Papers on the identification of microorganisms will also be considered, but detailed taxonomic studies do not fall within the scope of the journal. Case reports will not be published, unless they have general application or contain novel aspects. Papers of geographically limited interest, which repeat what had been established elsewhere will not be considered. The readership of the journal is global.